Multi-center comparative trial of efficacy and safety of Symbicort Turbuhaler versus routine antiasthmatic therapy in patients with stable bronchial asthma
Abstract
Combined administration of long-acting [32-agonists and inhaled glucocorticosteroids is a modern standard of long-term therapy for bronchial asthma (BA). From this point of view combined drugs such as Symbicort (budesonide+formoterol) appear to be the most perspective. The aim of this study was to assess clinical efficacy of Symbicort compared with usual therapy given to BA patients in Moscow policlinics.
Methods: this multi-center comparative trial with retrospective control involved 329 BA patients aged 10 to 75 years observed in 53 policlinics of Moscow and Moscow region. The patients received Symbicort 320/9 to 640/18 meg daily. The efficacy of the treatment was evaluated by peak expiratory flow rate (PEF), control for the disease signs (using the ACQ scale), seeking for medical care and quality of life.
Conclusion: Symbicort allows to reduce the symptom s intensity, better control the disease, to increase PEF values, to decrease the need of bronchodilators and to improve the quality of life in patients with stable BA of various severity compared with usual BA treatment. According to the results Symbicort is more effective than the usual therapy generally given to BA adults and children in Moscow.
About the Authors
A. N. Tsoy
Московская медицинская академия им. И. М. Сеченова
Russian Federation
Russian Federation
G. V. Demidova
Московская медицинская академия им. И. М. Сеченова
Russian Federation
Russian Federation
V. V. Arkhipov
Московская медицинская академия им. И. М. Сеченова
Russian Federation
Russian Federation
References
1. Shrewsbury S., Pyke S., Britton M. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). Br. Med. J. 2000; 320; 1368-1379.
2. Woolcock A., Lundback B., Ringdal N., Jacques L.A. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am. J. Respir. Crit. Care Med. 1996; 153: 1481-1488.
3. NHLB1/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. NIH Publication № 02-3659. 2002 1-177.
4. Aubier M., Pieters W.R., Schlosser N.J., Steinmetz K.-O. Salmeterol/fluticasone propionate (50/500 mug) in combination in a Diskus® inhaler (Seretide®) is effective and safe in the treatment of steroid-dependent asthma. Respir. Med. 1999; 93: 876-884.
5. Ericsson K., Bantje T.A., Huber R. et al. Cost-effectiveness of budesonide and formoterol in a single inhaler compared to fluticasone in the treatment of asthma. Eur. Respir. J. 2001; 18 (suppl.33): 157s.
6. Aalbers R., Backer V., Kava T.T.K. et al. Adjustable dosing with budesonide/formoterol reduces the rate of asthma exacerbations compared with fixed dosing salmeterol/fluticasone. Allergy Clin. Immunol. Int. — J. Wld Allergy Org. 2003; 15 (suppl.l): 50.
7. Stallberg B., Olsson P., Jolgersen L.A. et al. Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing. Int. J. Clin. Pract. 2003; 57 (8): 656-661.
8. Fitzgerald M. et al. In: Abstract presented at 13th Congress of European Respiratory Society. Vienna; 2003.
9. Zetterstrom O., Buhl R., Mellem H. et al. Symbicort (budesonide/formoterol in a single inhaler) improves asthma control and exacerbations rate in adult patients. Allergy 2001; 56 (suppl.68): 281.
10. Tal A., Simon G., Vermeulin G.H. et al. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Pediatr. Pulmonol. 2002; 34 (5): 342-350.
11. Lallo U.G., Malolepszy J., Kosma D. et al. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to moderate asthma. Chest 2003; 123 (5): 1480-1487.
12. American Thoracic Society. Standardization of spirometry 1994 update. Am. J. Respir. Crit. Care Med. 1995; 152: 1107.
13. Juniper E.F., О Byme P.M., Guyatt C.H. et al. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J. 1999; 14: 902-907.
14. Чучалин А.Г. Белая книга. Пулмонология. Россия 2003. M ; 2003.
Review
For citations:
Tsoy A.N., Demidova G.V., Arkhipov V.V. Multi-center comparative trial of efficacy and safety of Symbicort Turbuhaler versus routine antiasthmatic therapy in patients with stable bronchial asthma. PULMONOLOGIYA. 2004;(1):83-88. (In Russ.)
Views:
292
Email this article 